|
|
|
|
|
|
By Ionna Deni, contract market researcher, BioPlan Associates | In 2023, biomanufacturers showed an increasing interest in continuous manufacturing, but uptake, believe it or not, slowed down. Let’s explore the reasons why with data from BioPlan Associates. |
|
|
| CMC And Quality Considerations When Engaging Your CDMO | Article | By Bikash Chatterjee, Pharmatech Associates - A USP Company | Before pursuing an outsourcing strategy, it is essential to define what processes will be kept in-house and where your CDMO partner will take the lead. |
|
|
| Liposomal And Nanoparticle Technology | White Paper | Pfizer CentreOne | Specializing in oncology, anti-infective and complex formulations, the facility provides end-to-end services from development through to commercial manufacture of sterile dosage forms. |
|
|
| Delivering Market Success For Pharma Partners From Concept To Patient | Article | By Shari Krusniak and Patrick McLoughlin, West Pharmaceutical Services, Inc. | The development of drug delivery devices that are innovative, intuitive, patient friendly, and patient safe must address certain areas of concern that are particular to both biologic and biosimilar therapies. |
|
|
|
| 5 New Questions To Ask Before Signing With A Biologics CDMO | Article | By Abby Sorensen, Scorpius BioManufacturing | Outsourcing is now a true collaboration in which innovators and CDMOs co-create the future of medicine. Explore how the right CDMO can help sponsors unlock the full potential of their biotherapeutics. |
|
|
|
| Accelerating Rare Disease Treatments From Concept To Cure | Webinar | FUJIFILM Diosynth Biotechnologies | Access a thorough investigation that delves into the critical aspects of expediting curative therapies, with a focus on the strategic role that CDMOs can play in this transformative journey. |
|
|
| Optimizing The Formulation For A Monoclonal Antibody | Case Study | MilliporeSigma | An emerging biotech company sought help developing a formulation for a monoclonal antibody. Explore how MilliporeSigma delivered an optimized formulation within an aggressive timeline and budget. |
|
|
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|